早期和晚期肝细胞癌之间转移和预后的比较:基于人口的研究
Hanlong Zhu1, Si Zhao2, Tianming Zhao3
1Department of Gastroenterology and Hepatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Heliyon
|May 1, 2024
概括
早期发病的肝细胞癌 (HCC) 呈现出更远的转移 (DM),但显示出比晚期发病的HCC更好的预后. 需要进一步的研究来了解这些与年龄相关的肝癌差异.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 在瘤学瘤学.
- 癌症流行病学癌症流行病学
背景情况:
- 肝细胞癌 (HCC) 是一种异质性疾病,与远程转移 (DM) 和预后的年龄相关差异知之甚少.
- 早期发病的HCC被定义为50岁之前的诊断,与晚期发病的HCC相比.
研究的目的:
- 综合分析早期和晚期HCC之间的DM和预后差异.
- 根据诊断时的年龄,识别DM的风险因素和HCC的生存预测因素.
主要方法:
- 来自SEER数据库和医院队列的HCC患者数据的回顾性分析.
- 1:1倾向分数匹配 (PSM) 调整以考虑混因素.
- 逻辑回归,考克斯分析,卡普兰-梅尔曲线和日志等级测试被用来评估DM和生存率.
主要成果:
- 与晚期出现的HCC相比,早期出现的HCC与女性性别,较大的瘤,差差分化,晚期和较高的DM率有关.
- 尽管DM风险较高,但早期出现的HCC是PSM后生存的独立有利预测指标.
- 这些发现在独立的医院队列中得到了验证.
结论:
- 早期发病的HCC虽然更容易患DM,但与晚期发病的HCC相比,其预后更好.
- 这些与年龄相关的HCC差异的潜在病因基础需要进一步调查.
更多相关视频
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178


